Actuate Therapeutics (ACTU) vs Neuphoria Therapeutics (NEUP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Neuphoria Therapeutics (NEUP) has outperformed Actuate Therapeutics (ACTU) over the past year, losing 81.8% versus a loss of 89.7%. Neuphoria Therapeutics is the larger company by market cap ($18.4 million vs $15.6 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACTU | NEUP |
|---|---|---|
| Share price | $0.6503 | $3.40 |
| Market cap | $15.62M | $18.40M |
| 1-day change | -10.20% | -0.58% |
| YTD return | -88.17% | -11.86% |
| 1-year return | -89.71% | -81.78% |
| EPS (TTM) | $-0.87 | $-3.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.49 | $19.21 |
| 52-week low | $0.604 | $3.19 |
| Distance from 52-week high | -92.34% | -82.30% |
| Average volume | 391.80K | 162.11K |
| Shares outstanding | 24.01M | 5.41M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ACTU vs NEUP FAQ
Which is bigger, Actuate Therapeutics or Neuphoria Therapeutics?
Neuphoria Therapeutics (NEUP) is larger, with a market capitalization of $18.40M compared with $15.62M for Actuate Therapeutics (ACTU).
Which stock has performed better over the past year, ACTU or NEUP?
NEUP returned -81.78% over the past 12 months, compared with -89.71% for ACTU (price return, excluding dividends). Past performance does not predict future results.
Are Actuate Therapeutics and Neuphoria Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.